December 2, 2019
A key health ministry advisory panel on November 29 gave its blessing to the approval of a batch of new drugs and indications including Eisai’s insomnia medicine lemborexant and Mundipharma’s anesthetic agent remimazolam. The Pharmaceutical Affairs and Food Sanitation Council’s...read more